X

JK Pharmachem Ltd Stock Analysis

Small Cap
Evaluated by 27 users | BSE: 500218 | NSE: JKPHARMA |
Pharmaceuticals & Drugs
JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU. The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Sep'96Sep'97Sep'98Sep'99Sep'00Sep'01Sep'02Sep'03Sep'04Sep'05
Return on Capital Employed 00-0.54%-4.15%-7.86%-4.44%7.86%-1.24%-19.63%-5.58%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0071.868.572.970.395.378.438.45.2
Y-o-Y Gr. Rt.-NANA-4.5%6.3%-3.5%35.5%-17.8%-51%-86.4%
Adjusted EPS (Rs.) 00-3.57-4.8-3.67-2.270.66-1.13-4.86-1.71
Y-o-Y Gr. Rt.-NANANANANANA-271.2%NANA
Book Value per Share (Rs.) 009.264.552.870.752.681.86-4.03-5.97
Adjusted Net Profit 00-14.8-19.9-23-14.24.2-7.1-30.5-10.7
Net Op. Cash Flow (Rs. Cr.) 008.686.48.213.18.22.43.5
Debt to Cash Flow from Ops 0016.0417.4116.2813.087.8712.2744.1131.38
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
JK Pharmachem Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NA-41%-62%-86.4%
Adjusted EPS NANA-237.4%NA
Book Value per Share 0-215.8-230.60
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Sep'96Sep'97Sep'98Sep'99Sep'00Sep'01Sep'02Sep'03Sep'04Sep'05
Return on Equity (%) 00-33.46-50.89-52.8-30.989.47-15.22-121.49-7629.21
Operating Profit Margin (%) 0016.559.70.447.4821.8911.49-37.22-81.6
Net Profit Margin (%) 00-20.59-29-31.57-20.214.37-9.05-79.38-204.44
Debt to Equity 003.614.852.122.972.142.3317.66-18.21
Working Capital Days 00013612111390123196684
Cash Conversion Cycle 0005245292973123-121
No Data To Display
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU.

The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the company is under receivership now. It has been suspended from BSE on account of non compliance with listing agreement clauses.

The registered office of the company is located at A-7 SIPCOT Industrial

JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU.

The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the company is under receivership now. It has been suspended from BSE on account of non compliance with listing agreement clauses.

The registered office of the company is located at A-7 SIPCOT Industrial Complex, South Arcot, Vallalar district, Cuddalore, Tamil Nadu-607005.

Business area of the company

The company is engaged in the manufacture of drugs and pharmaceuticals.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback